Criminal Prosecution of Par Pharmaceutical Inc.

In August 2011, Par Pharmaceutical, Inc. paid $90.9 million to resolve allegations that Par knowingly reported inflated drug prices and thereby caused the submission of false claims to the Medicaid program.

Source: HHS Health Care Fraud and Abuse Control Program, Annual Report for FY 2011

This article was posted on July 15, 2012.

Links to Recommended Companies